Novo Nordisk Shares Fall on Pipeline Concerns, CEO Reveals Main Source of Problem

Novo Nordisk shares have fallen amid pipeline concerns, and the CEO's statements have increased uncertainty. Technical indicators are mixed: the price is slightly above the SMA20 but below the SMA50, the RSI is in neutral territory, and the MACD is positive above the signal line. I think the news could create short-term selling pressure, but the current technical picture is not overly weak. In the 1-3 day horizon, I estimate that downside risk may be limited and that bargain hunting could emerge. Nevertheless, volatility may increase depending on the news flow.

NOV stock declined 4.4% in 24 hours to 20.06, with RSI at 33.6 approaching oversold territory. MACD is below the signal line and in negative territory, and the price is trading below the 20- and 50-day moving averages, confirming weak short-term momentum. Pipeline concerns in the news and the CEO's explanation of the main source of the problem could increase uncertainty in the fundamental outlook and sustain selling pressure. However, with RSI near the oversold threshold, there is a possibility of a limited rebound on bargain hunting. Nevertheless, in light of current technical and news flow, the 1-3 day direction appears downward.